The ROC curve analysis evaluated the potential of serum IGF-1, IGFBP-3, and the IGF-1/IGFBP-3 molar ratio as predictors of thyroid nodules in patients with T2DM. The gene discussed is IGFBP3; the disease is thyroid nodule.